March 13, 2014

The epilepsy therapeutics market value in the eight major countries — the United States, Canada, France, Germany, Italy, Spain, the United Kingdom and Japan — will increase from $3.4 billion in 2012 to $4.5 billion by 2019, at a compound annual growth rate of 3.9%, according to a new report from business intelligence provider GBI Research.

July 26, 2012

Qualitest Pharmaceuticals announced that it has received approval from the Food and Drug Administration for its generic version of an epilepsy treatment.

February 29, 2012

The Food and Drug Administration has approved a drug for epilepsy made by Hi-Tech Pharmacal, the drug maker said Wednesday.

January 3, 2012

The Food and Drug Administration has approved a drug for epilepsy made by Mylan, the drug maker said.

October 4, 2011

A wave of patent expirations over the next several years will open up a broad swath of drugs to generic competition, and India's Lupin Pharmaceuticals is looking to benefit, according to published reports.

September 16, 2011

Actavis has launched its version of an epilepsy drug made by UCB.

September 15, 2011

The Food and Drug Administration has approved a generic drug for epilepsy made by Lupin Pharmaceuticals, the drug maker said.

September 13, 2011

Watson Labs has begun shipping a drug designed to treat partial onset seizures in patients with epilepsy.

August 10, 2011

The Food and Drug Administration has approved a generic drug for epilepsy.

July 11, 2011

Generic drug maker Amneal has launched three new liquid drugs, the company said Monday.

February 1, 2010

The Food and Drug Administration has approved a generic epilepsy drug made by Taro Pharmaceutical...